Evidence map›Paper›PMID 41772802›Full record

ArticleProtein science : a publication of the Protein Society2026

ApoJ regulates endothelial lipase activity and stability.

Uriel L Jean-Baptiste, Simcha R Singh, Ming J Wu, Kellen Christina da Cruz Rodriguez, Young-Bum Kim, Saskia B Neher

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. ApoJ regulates endothelial lipase activity and stability.Protein science : a publication of the Protein Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Uriel L Jean-BaptisteDepartment of Biochemistry and Biophysics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA.
Simcha R SinghDepartment of Biochemistry and Biophysics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA.
Ming J WuDepartment of Biochemistry and Biophysics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA.
Kellen Christina da Cruz RodriguezDivision of Endocrinology, Diabetes, and Metabolism, Beth Isreal Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Young-Bum KimDivision of Endocrinology, Diabetes, and Metabolism, Beth Isreal Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Saskia B NeherDepartment of Biochemistry and Biophysics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0003-4165-6674

Funding

Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
Investigation of the Molecular Mechanisms of Lipoprotein Lipase InhibitorsR01HL125654 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NEHER, SASKIA · 2015 to 2024
$3.8M
Role of LRP1 in Alzheimer’s diseaseR01AG080842 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI YOUNG-BUM KIM · 2023 to 2026
$3.3M
Lipoprotein Lipase Through the Secretory SystemR01HL163352 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Saskia Neher · 2023 to 2026
$1.5M
American Diabetes Association 1-25-PDF-49NHLBI NIH HHS R01 HL125654NHLBI NIH HHS R01 HL163352NIH HHS R01AG080842NIH HHS RO1HL125654NIH HHS RO1HL163352NIH HHS T32HL069768Pfizer 67170875
6 · The paper itself

Abstract

Endothelial lipase (EL) is a key regulator of high-density lipoprotein (HDL) metabolism. Many aspects of EL function remain incompletely understood due to challenges in purifying active EL. This study identifies apolipoprotein J (ApoJ) as a novel chaperone for EL, crucial for its solubility and activity. Using an optimized purification protocol that yields active EL, we discovered that ApoJ consistently co-purifies with EL, maintaining its activity. We further show that knocking down ApoJ decreases the activity of EL. We demonstrate that ApoJ interacts with EL via its hydrophobic lid and tryptophan loop regions, and that mutating these regions abolishes the effect of ApoJ on the solubility and activity of EL. We show that ApoJ, EL, and ApoA1 (the defining lipoprotein of HDL particles) colocalize in HDL particles in mouse plasma. However, we find that ApoJ is not a direct carrier for EL to HDL particles. Instead, our data suggest that ApoJ primarily serves to enhance EL activity through its role as a chaperone, even when incorporated into lipid substrates. Our findings suggest a model in which ApoJ protects EL in plasma and enhances its hydrolysis of lipoprotein substrates. We propose that ApoJ is an accessory protein for EL, analogous to GPIHBP1 for LPL and co-lipase for PL. Further study of the interaction between EL and ApoJ will promote a better understanding of HDL metabolism.

Indexed as

LipaseMolecular ChaperonesAnimalsApolipoprotein A-IEnzyme StabilityHumansLipoproteins, HDLMiceApolipoprotein A-ILipaseLIPG protein, humanLipg protein, mouseLipoproteins, HDLMolecular Chaperonesapolipoprotein Jchaperoneclusterinendothelial lipasehepatic lipasehigh‐density lipoproteinlipoprotein lipaselipoprotein metabolismpancreatic lipase

Identifiers

PMID41772802
PMCPMC12953197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.